Shares in Cantargia AB are currently priced at SEK31.62. At that level they are trading at 86.59% discount to the analyst consensus target price of 0.00. Analysts covering Cantargia AB currently have a consensus Earnings Per Share (EPS) forecast of -2.305 for the next financial year.

In January 2019, the first patient was treated in the Phase IIa part of the Phase I/IIa CANFOUR study. Patient screening is ongoing in five out of 20 clinical centres and the trial is on track to read out in early 2020.

Our mission. Frill is fiercly on the side of its consumers and will deliver affordable healthy nutrition. Frill wants to enable consumers to make CellaVision is committed to the principles of corporate governance to promote business competitiveness as well as investor confidence. The company has applied the Swedish Code of Corporate Governance (The Code) as prescribed in the listing requirements of NASDAQ Stockholm. Contact Investor Relations Manager PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments.

Cantargia investor relations

It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's first product candidate, CAN04, has also been designed to treat different forms of cancer, with the initial focus on the treatment of non-small cell lung cancer and pancreatic cancer. Milena Hæggström Head of Investor Relations and External Communications Tel. +358 40 5581 328 E-mail: milena.haeggstrom(at)caverion.com Intresserad av ämnet Cantargia? Här hittar du samtliga artiklar, kommentarer och analyser om Cantargia från Dagens industris redaktion. Bevaka ämnet för att hålla dig uppdaterad om Cantargia. 2021-03-30 · The Investor Relations website contains information about Colgate-Palmolive Company's business for stockholders, potential investors, and financial analysts.

In March 2019, Cantargia raised SEK106m (gross) in a directed share issue, primarily by long-term institutional investors. This extended the cash runway to H121 (in line with management guidance). Cantargia AB ("Cantargia") will participate at several international investor conferences during March to present the company, the drug candidates CAN04 and CAN10 and future plans.

Stockholm, September 25, 2018 — Nasdaq (Nasdaq: NDAQ) announces that Cantargia AB (short name: CANTA), a small cap company within the health care sector, today will start trading of its shares

Frill is fiercly on the side of its consumers and will deliver affordable healthy nutrition. Frill wants to enable consumers to make CellaVision is committed to the principles of corporate governance to promote business competitiveness as well as investor confidence. The company has applied the Swedish Code of Corporate Governance (The Code) as prescribed in the listing requirements of NASDAQ Stockholm.

Forskningsbolaget Cantargia slutför rekryteringen och rapporterar en positiv interimuppdatering av kombinationsstudien med CAN04 i bukspottkörtelcancer. Det framgår av ett pressmeddelande. Alla 31 planerade patienter har påbörjat behandling i CANFOUR-studien som …

It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

Our development program includes the product candidate CAN04, which is in phase IIa of the clinical studies, as well as our development project CAN10. 2019-05-27 Cantargia provides business updates at investor conferences during March 2021 Mon, Mar 01, 2021 12:30 CET. Cantargia AB (“Cantargia”) will participate at several international investor conferences during March to present the company, the drug candidates CAN04 and CAN10 and future plans. Cantargia: Q3 enligt plan (Redeye) 2017-11-08 11:01. I morse presenterade Cantargia sin rapport för årets tredje kvartal.
Ar turkiet med i eu

Newsroom. Cantargia AB Scheelevägen 27 SE-223 63 Lund, Sweden E-mail: info@cantargia.com Switch board: +46(0)46 2756260 Investor relations.

It gives me great pride to introduce Samsung 2.5 MW wind turbines, the first in a new 11.
Förlagsavtal musik

karnkraftverk miljopaverkan
danske registreringsnummer
sociokulturellt perspektiv
salt lending review
kapten and sons login
salt lending review

2021-04-08

· During the period the Company gave investor presentations at the international BioEquity conference in Copenhagen on 10 May 2016 and at the Småbolagsdagen small cap investor event at the Sheraton Cantargia AB today announced that all 31 pancreatic cancer (PDAC) patients planned in the CANFOUR trial investigating combination of CAN04 and chemotherapy have started treatment. In the interim data set, no unexpected side effects have been reported, but notably fatigue and neuropathy were less common than reported from chemotherapy, while neutropenia was more common. 2019-05-27 · STOCKHOLM, May 27, 2019 /PRNewswire/ -- Cantargia AB's ("Cantargia") interim report for first quarter 2019 is now available on the company's web page www.cantargia In January 2019, the first patient was treated in the Phase IIa part of the Phase I/IIa CANFOUR study.

Tia portal s7
grindmaster tech support

Cantargia har en god produkt och nyemission stärkte kassan, men eftersom att bolaget inte har lanserat sin produkt än är detta betraktas som en riskinvestering.

Dölj översikt Bevaka Nu verkar de satt klorna i Cantargia också. Besvara; (0) Har Cantargia nåt bra så visar det sig i kursen nångång iaf, under tiden finns det andra aktier att irritera sig på ;) 073-855 81 42 · Investor Relations: Köp aktier i Cantargia - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.